This site contains information about prescription peptide therapy protocols intended for adults. You must be 18 years of age or older to enter.
By entering, you confirm you are at least 18 years old and agree to our Terms of Service. All protocols require a valid physician prescription.
A synthetic analogue of GHRH that stimulates the anterior pituitary to release growth hormone in natural pulses — supporting body composition, sleep quality, recovery, and the biology of healthy aging.
Sermorelin (GHRH 1-29 NH₂) is a synthetic analogue of the first 29 amino acids of growth hormone-releasing hormone (GHRH) — the natural signal the hypothalamus sends to the pituitary to trigger growth hormone release. It was first approved by the FDA in 1997 for pediatric growth hormone deficiency, making it one of the most established GH-related peptides in clinical medicine.
Unlike synthetic human growth hormone (hGH), sermorelin does not suppress the body's natural GH production. Instead, it works upstream — stimulating the pituitary to release GH in natural pulses, mirroring the body's circadian rhythm. GH secretion peaks during deep sleep, which is why sermorelin is administered at bedtime to align with this natural cycle.
The downstream effects come through IGF-1 (insulin-like growth factor 1), produced in the liver in response to GH pulses. IGF-1 drives the muscle-building, fat-burning, and tissue-repair effects associated with healthy GH levels. As GH and IGF-1 decline naturally after age 30, sermorelin offers a way to restore pulsatile GH secretion without suppressing the pituitary feedback loop.
Increased GH and IGF-1 levels support lean muscle development and reduction of adipose tissue — particularly visceral fat — with consistent use over 3–6+ months.
Sermorelin administered before bed enhances slow-wave (deep) sleep — the stage most associated with physical recovery, memory consolidation, and GH secretion.
Users commonly report improved daytime energy, mental clarity, and reduced fatigue — downstream effects of restored GH/IGF-1 levels and improved sleep architecture.
GH is a primary driver of tissue repair and recovery. Sermorelin supports faster healing from training stress and injury by elevating the GH signaling that the body relies on for regeneration.
Unlike synthetic hGH, sermorelin preserves the pituitary's natural feedback loop — it stimulates rather than replaces GH production, maintaining the axis intact over time.
IGF-1 stimulates collagen synthesis and skin thickness. Long-term sermorelin users often report improvements in skin texture and elasticity consistent with restored GH activity.
Sermorelin is administered subcutaneously, typically at bedtime to align with the body's natural GH pulse cycle. Injecting 30–60 minutes before sleep allows the peptide to stimulate GH release during the early deep-sleep phase when somatostatin levels are lowest and the pituitary is most responsive.
Effects build gradually over 3–6 months as IGF-1 levels normalize. Many researchers run sermorelin for 6 months on, 1–2 months off.
| Parameter | Detail |
|---|---|
| Standard Dose | 200 – 500 mcg per injection |
| Timing | At bedtime (30–60 min before sleep), on an empty stomach |
| Frequency | Daily (5 days on / 2 days off is a common community variant) |
| Route | Subcutaneous — abdomen or upper thigh |
| Cycle Length | 3 – 6 months continuous; 1–2 month break before repeat |
| Storage | Lyophilized: refrigerate. Reconstituted: use within 30 days, keep refrigerated. |
Sermorelin has more clinical research behind it than most peptides — it spent years as an FDA-approved pediatric drug before being withdrawn from the market (for commercial, not safety reasons). Human data spans growth hormone deficiency, body composition, and anti-aging research in adults.
Sermorelin was FDA-approved (brand name Geref) for pediatric GH deficiency, providing a substantial clinical safety and efficacy database for the GHRH 1-29 molecule before withdrawal in 2002.
Studies in older adults show sermorelin administration normalizes GH pulse amplitude and IGF-1 levels, with outcomes including increased skin thickness and activation of the somatotropic axis.
Research confirms sermorelin enhances slow-wave sleep — the stage responsible for physical recovery and the body's primary GH secretion window — when administered at bedtime.
GHRH analogue studies show improvements in lean mass and reduction in adipose tissue with chronic use, mediated through GH/IGF-1 axis restoration rather than direct anabolic signaling.
Sermorelin is often combined with a GHRP (growth hormone releasing peptide) for a synergistic GH pulse — GHRH + GHRP together produce a larger, more sustained GH release than either alone.
Synthetic HGH bypasses the pituitary and delivers GH directly — it works faster but suppresses natural production and carries more regulatory scrutiny. Sermorelin works upstream, stimulating the pituitary to produce GH naturally in pulses. This preserves the feedback loop, is considered a safer long-term approach, and maintains the pulsatile pattern that matters for GH physiology.
The majority of natural GH secretion occurs during slow-wave sleep. At bedtime, somatostatin (the GH inhibitor) is at its lowest, making the pituitary most responsive to GHRH signals. Sermorelin timed to sleep onset amplifies the body's existing GH pulse rather than creating an out-of-phase spike.
Sermorelin is not a fast-acting compound. IGF-1 normalization takes weeks, and tissue-level changes (body composition, skin, energy) are most apparent at 3–6 months. Most researchers report the first noticeable changes — improved sleep quality and recovery — within 4–8 weeks.
Yes — this is one of the most well-regarded GH stacks in the research community. Sermorelin acts through the GHRH receptor; ipamorelin acts through the ghrelin receptor. Combined, they produce a larger, more sustained GH pulse than either alone, without significant cortisol or prolactin elevation.
Minimum ≥99% purity with a third-party COA confirming peptide identity and absence of contaminants. Cinch Bio sources through Finnrick Analytics-verified suppliers — batch COAs available on request.
Sermorelin is sold for research purposes only. While it has historical FDA approval for pediatric use, it is not currently approved for anti-aging or adult body composition applications. The information on this page is educational and does not constitute medical advice. Consult a qualified healthcare professional before considering any peptide protocol.
Third-party tested sermorelin with Finnrick Analytics verification. Full COA on every batch. Ships within 24 hours.
Get Started TodayMedical Disclaimer: The information on this page is for educational purposes only and does not constitute medical advice. All protocols require evaluation and prescription by a licensed physician. You should consult a qualified healthcare provider before starting any new medical protocol. Individual results vary. Cinch Bio is not a pharmacy and does not dispense medications — all prescriptions are issued by independent licensed physicians and filled by licensed 503A compounding pharmacies.